Latest Period
Q2 2026
Security Snapshot
KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) Institutional Ownership
CUSIP: 48669G303
13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026
Institutions Reporting
36
Shares (Excl. Options)
3,639,348
Price
$14.08
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / American Depositary Shares, each representing five-hundred Ordinary Shares
- Symbol
- KZIA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 3,639,348
- Total 13F value
- $50,727,105
- Portfolio coverage rank
- 0%
- Share change
- +1,856,479
- Value change
- +$28,686,748
- Number of holders
- 36
- Shares outstanding
- 11,750,571
- SEC-reported price per share
- $12.26
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares is tracked under CUSIP 48669G303.
- 36 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 23 to 36 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $13,047,820 to $50,727,105.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 36 institutions filings for Q2 2026.
Security key
48669G303
Latest holder period
Q2 2026
13F holders
36
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
KZIA full holder history
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
KAZIA THERAPEUTICS LTD insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 48669G303:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
KZIA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | 4.6% | -16% | $3,601,084,995 | -$584,614,620 | 264,980,500 | -14% | Lynwood Capital Management Inc. | 30 Jun 2026 |
| Ikarian Capital, LLC | 4.9% | -4% | $7,824,823 | -$67,624 | 575,778 | -0.86% | Ikarian Capital, LLC | 30 Jun 2026 |
As of 30 Jun 2026, 36 institutional investors reported holding 3,639,348 shares of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA). This represents 31% of the company’s total 11,750,571 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
31%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Boxer Capital Management, LLC | 4.8% | 560,000 | 0.59% | $7,884,800 | |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 3.5% | 414,958 | +191% | 0.07% | $5,842,609 |
| Bleichroeder LP | 3.4% | 400,000 | 0% | 1% | $5,632,000 |
| Ikarian Capital, LLC | 3.4% | 396,201 | 0.92% | $5,578,510 | |
| Dauntless Investment Group, LLC | 3% | 354,208 | +344% | 8.6% | $4,987,249 |
| Stonepine Capital Management, LLC | 2.9% | 345,179 | 0% | 3.7% | $4,860,120 |
| Point72 Asset Management, L.P. | 1.7% | 200,300 | +0.15% | 0% | $2,304,224 |
| Ensign Peak Advisors, Inc | 0.94% | 110,778 | 0% | $1,559,754 | |
| MILLENNIUM MANAGEMENT LLC | 0.86% | 101,376 | 0% | $1,427,374 | |
| UBS Group AG | 0.69% | 81,090 | +482% | 0% | $1,141,748 |
| J. Goldman & Co LP | 0.58% | 68,491 | 0.03% | $964,353 | |
| ADAR1 Capital Management, LLC | 0.52% | 61,550 | 0.04% | $866,624 | |
| JANE STREET GROUP, LLC | 0.49% | 57,140 | 0% | $804,531 | |
| BARCLAYS PLC | 0.49% | 56,999 | +138% | 0% | $802,546 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.43% | 50,616 | 0% | $712,673 | |
| COOPERMAN LEON G | 0.43% | 50,000 | 0.02% | $704,000 | |
| Westside Investment Management, Inc. | 0.4% | 47,585 | -5.6% | 0.09% | $669,997 |
| MORGAN STANLEY | 0.4% | 46,606 | +4561% | 0% | $656,212 |
| MARSHALL WACE, LLP | 0.38% | 44,231 | 0% | $622,772 | |
| XTX Topco Ltd | 0.27% | 31,186 | 0.01% | $439,099 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.26% | 30,090 | 0% | 0% | $423,667 |
| CITADEL ADVISORS LLC | 0.24% | 28,509 | 0% | $401,407 | |
| RAYMOND JAMES FINANCIAL INC | 0.19% | 22,599 | +43% | 0% | $318,194 |
| Sequoia Financial Advisors, LLC | 0.17% | 20,003 | -67% | 0% | $281,643 |
| Engineers Gate Manager LP | 0.13% | 14,975 | 0% | $210,848 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 3,639,348 | $50,727,105 | +$28,686,748 | $14.08 | 36 |
| 2026 Q1 | 1,753,860 | $13,047,820 | -$4,850,511 | $7.44 | 23 |
| 2025 Q4 | 2,479,478 | $17,070,899 | +$14,797,378 | $6.89 | 22 |
| 2025 Q3 | 158,075 | $1,139,856 | +$101,771 | $7.21 | 11 |
| 2025 Q2 | 144,017 | $902,466 | +$902,466 | $6.27 | 10 |